MSF welcomes GSK's decision to lower the price of the pneumonia vaccine for some of the world's most vulnerable children.
On September 20th, 2016 Médecins Sans Frontiéres/Doctors without Borders (MSF) welcomed the decision by GlaxoSmithKline (GSK) to lower its price of its pneumococcal conjugate vaccine (PCV) for humanitarian organizations that serve refugee and crisis-affected children.
Read on for the entire announcement here.
Nov 24, 2024
Violence against women and girls remains one of the most prevalent and pervasive human rights violations in the world. Globally, almost one in three women have been subjected to physical and/or... Read more
Nov 15, 2024
“A group of governments, multilateral development banks, UN agencies, and some of the world’s largest philanthropic organizations are announcing expanded efforts and increased coordination and... Read more
Nov 12, 2024
“The right funding now can protect the frontlines of the climate crisis from the worst effects of extreme weather events. For many developing countries, particularly in Africa, the cost of... Read more